M
any patients with thoracic outlet syndrome develop a chronic pain syndrome (1) . Some of these patients require surgical decompression of the thoracic outlet to alleviate their symptoms. Surgical decompression is accomplished by performing a first rib resection with cervical sympathectomy. There are 2 approaches to first rib resection, supraclavicular and transaxillary. The preferred surgical technique at Baylor University Medical Center is transaxillary (2) (3) (4) . Postoperative pain management for patients with thoracic outlet syndrome is compounded by the fact that most of these patients are on long-term potent analgesics at home before the operation.
In an effort to improve the management of acute postoperative pain, a cervical-thoracic paravertebral regional block (PVB) was introduced into the anesthetic regimen (5, 6) . This block has been used successfully in the management of postthoracotomy pain (7) (8) (9) and has been shown to be safe and effective (10) . Postanesthesia care unit (PACU) nurses reported a noticeable improvement in pain management in the patients who had a PVB with first rib resection. Therefore, the goal of this retrospective study was to evaluate the efficacy and safety of PVB in the prevention and management of pain in patients who undergo a first rib resection with cervical sympathectomy.
METHODS
After institutional review board approval was obtained, the authors reviewed the charts of 68 consecutive patients who had received a transaxillary first rib resection with cervical sympathectomy for pain from thoracic outlet compression from January 1998 to June 2000. Data analyzed included prescribed preoperative pain medications, analgesia usage via a patientcontrolled analgesia pump, and pain scores at hospital admission, PACU admission, and PACU discharge. Morphine equivalents were calculated for meperidine, fentanyl, and other narcotics. On the pain scale, 0 indicates no pain, and 10 denotes the worst pain imaginable. All scores were whole numbers. Three patients were admitted to the PACU with pain scores of 10. The PVB was assumed to have failed in these 3 patients, and they were excluded from analysis, leaving 26 patients in the general anesthesia (GA) plus PVB group and 39 patients in the GA-only group.
All patients received GA from the same anesthesiologist. The PVB was performed at the C7 and T1 levels with up to 10 mL of 0.5% ropivacaine injected at each site, for a total dose not exceeding 0.5 mg/kg. Values are given as mean ± SD unless otherwise indicated.
GA indicates general anesthesia; PVB, paravertebral block; PACU, postanesthesia care unit.
Data were examined using nonparametric statistical analysis with the Wilcoxon signed rank test and repeated measures of variance. A P value <0.05 was considered significant.
RESULTS
The mean age, weight, and preoperative narcotic usage were similar in both groups (Table 1) . Narcotic usage, as determined by morphine equivalents, was found to be similar in both groups when compared in the PACU, on postoperative day 1, and in Values represent morphine equivalents (mg/kg) and are given as mean ± SD.
PACU indicates postanesthesia care unit.
total usage (Table 1) . Both groups had similar preoperative pain scores. However, when pain scores were evaluated on PACU admission and discharge, there was a statistically significant decrease in pain for patients receiving PVB and GA compared with patients receiving GA alone. There was also a significant reduction in pain at PACU discharge in patients who received PVB plus GA when compared with pain on admission to the hospital. This was not significant in patients who received only GA (Table 1) . Patients who received a PVB plus GA had no significant difference in narcotic use whether they were on preoperative chronic pain medications or not. Overall postoperative total narcotic usage based on weight was significantly higher in patients who were on chronic pain medications at home (Table 2 ).
DISCUSSION
Our study showed that PVBs for first rib resections result in a significant decrease in postoperative pain but no significant decrease in opioid usage. Some authors have questioned the consistency of analgesia results with PVB. Twenty-six of 29 patients in our series had successful PVBs. No patients experienced any toxic effects from the analgesic used for the PVB or any injection site-related complications. By comparison, another method used-an intercostal block with continuous infusion-has led to hypotension and bladder dysfunction (11) (12) (13) (14) (15) (16) .
We found that patients using preoperative pain medication had significantly higher narcotic requirements in the hospital than nonusers. Other factors may contribute to this finding, such as psychological, social, and behavioral issues related to chronic use.
PERIOPERATIVE PAIN MANAGEMENT AFTER FIRST RIB RESECTION
Adding PVB to perioperative analgesia management has led to great satisfaction for our patients. PVB should be considered in all patients who are receiving a first rib resection with cervical sympathectomy.
